The epidemiology and healthcare costs of community-acquired pneumonia in Ontario, Canada: a population-based cohort study

References

• McNeil SA, Qizilbash N, Ye J, et al. A retrospective study of the clinical burden of hospitalized all-cause and pneumococcal pneumonia in Canada. Can Respir J. 2016;2016:3605834.
   PubMed Web of Science ®Google Scholar
• Weycker D, Farkouh RA, Strutton DR, et al. Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions. BMC Health Serv Res. 2016;16(1):182.
   PubMedGoogle Scholar
• Chalmers J, Akram A, Hill A. Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis. Eur Respir J. 2011;37(4):858–864.
   PubMed Web of Science ®Google Scholar
• Eurich DT, Marrie TJ, Minhas-Sandhu JK, et al. Ten-year mortality after community-acquired pneumonia: a prospective cohort. Am J Respir Crit Care Med. 2015;192(5):597–604.
   PubMed Web of Science ®Google Scholar
• Sato R, Rey GG, Nelson S, et al. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years. Appl Health Econ Health Policy. 2013;11(3):251–258.
   PubMedGoogle Scholar
• National Institute on Ageing. As one of Canada’s Top Killers, Why Isn’t Pneumonia taken more seriously? Toronto, ON: National Institute on Ageing; 2019.
   Google Scholar
• Canada S. Table 13-10-0394-01 leading causes of death, total population, by age group. Ottawa: Statistics Canada; 2017.
   Google Scholar
• Kwong JC, Ratnasingham S, Campitelli MA, et al. The impact of infection on population health: results of the Ontario burden of infectious diseases study. PLoS One. 2012;7(9):e44103.
   PubMed Web of Science ®Google Scholar
• Dobrescu A. The economic burden of pneumonia in Canada: a Status Quo Forecast. Ottawa: The Conference Board of Canada; 2017.
   Google Scholar
• Lebel MH, Kellner JD, Ford-Jones EL, et al. A pharmacoeconomic evaluation of 7-valent pneumococcal conjugate vaccine in Canada. Clin Infect Dis. 2003;36(3):259–268.
   PubMed Web of Science ®Google Scholar
• Petit G, De Wals P, Law B, et al. Epidemiological and economic burden of pneumococcal disease in Canadian children. Can J Infect Dis Med Microbiol. 2003;14(4):215–220.
   Google Scholar
• Carriere KC, Jin Y, Marrie TJ, et al. Outcomes and costs among seniors requiring hospitalization for community‐acquired pneumonia in Alberta. J Am Geriatr Soc. 2004;52(1):31–38.
   PubMed Web of Science ®Google Scholar
• Weycker D, Moynahan A, Silvia A, et al. Attributable cost of adult hospitalized pneumonia beyond the acute phase. PharmacoEconomics-Open. 2020;2020:1–10.
   Google Scholar
• Wasser T, Yu J, Singer J. Long-term cost consequences of community-acquired pneumonia in adults. Am J Pharm Benefits. 2013;5(3):e66–e72.
   Google Scholar
• Institute for Clinical Evaluative Sciences. ICES Data Dictionary 2020; [cited 2020 Nov 20]. Available from: https://datadictionary.ices/.
   Google Scholar
• Cadieux G, Tamblyn R. Accuracy of physician billing claims for identifying acute respiratory infections in primary care. Health Serv Res. 2008;43(6):2223–2238.
   PubMed Web of Science ®Google Scholar
• Hwee J, Sung L, Kwong JC, et al. Use of physician billing claims to identify infections in children. PLoS One. 2018;13(11):e0207468.
   PubMed Web of Science ®Google Scholar
• Harris H, Horst SJ. A brief guide to decisions at each step of the propensity score matching process. Pract Assess Res Eval. 2016;21(1):4.
   Google Scholar
• Health JHBSoP. The Johns Hopkins ACG System Technical Reference Guide, Version 9.0. Baltimore, MD: The John Hopkins University; 2009.
   Google Scholar
• Austin PC. Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150–161.
   PubMed Web of Science ®Google Scholar
• Wodchis WP, Bushmeneva K, Nikitovic M, et al. Guidelines on person-level costing using administrative databases in Ontario. Working Paper Series. Toronto: Health System Performance Research Network; 2013.
   Google Scholar
• Table 051-0001 – Estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual (persons unless otherwise noted) [Internet]. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710000501.
   Google Scholar
• Bordon J, Wiemken T, Peyrani P, et al. Decrease in long-term survival for hospitalized patients with community-acquired pneumonia. Chest. 2010;138(2):279–283.
   PubMed Web of Science ®Google Scholar
• Kaplan V, Clermont G, Griffin MF, et al. Pneumonia: still the old man’s friend? Archives of Internal Med. 2003;163(3):317–323.
   PubMedGoogle Scholar
• Sandvall B, Rueda AM, Musher DM. Long-term survival following pneumococcal pneumonia. Clin Infect Dis. 2013;56(8):1145–1146.
   PubMed Web of Science ®Google Scholar
• Bruns AH, Oosterheert JJ, Cucciolillo MC, et al. Cause‐specific long‐term mortality rates in patients recovered from community‐acquired pneumonia as compared with the general Dutch population. Clin Microbiol Infect. 2011;17(5):763–768.
   PubMed Web of Science ®Google Scholar
• Viasus D, Cillóniz C, Cardozo CG, et al. Early, short and long-term mortality in community-acquired pneumonia. Ann Res Hospitals. 2018;2(5):2.
   Google Scholar
• Ramirez JA, Wiemken TL, Peyrani P, et al. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017;65(11):1806–1812.
   PubMed Web of Science ®Google Scholar
• Johnstone J, Eurich DT, Majumdar SR, et al. Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study. Medicine. 2008;87(6):329–334.
   PubMed Web of Science ®Google Scholar
• File TM, Jr, Marrie TJ. Burden of community-acquired pneumonia in North American adults. Postgrad Med. 2010;122(2):130–141.
   PubMed Web of Science ®Google Scholar
• Luca DL, Kwong JC, Chu A, et al. Impact of pneumococcal vaccination on pneumonia hospitalizations and related costs in Ontario: a population-based ecological study. Clin Infect Dis. 2018;66(4):541–547.
   PubMed Web of Science ®Google Scholar
• Griffin MR, Zhu Y, Moore MR, et al. US hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med. 2013;369(2):155–163.
   PubMed Web of Science ®Google Scholar
• Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American thoracic society and infectious diseases society of America. Am J Respir Crit Care Med. 2019;200(7):e45–e67.
   PubMed Web of Science ®Google Scholar